Related references
Note: Only part of the references are listed.Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma
Xiaoli Liu et al.
CELL CYCLE (2013)
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco et al.
LANCET ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Telomeres and Cancer: From Crisis to Stability to Crisis to Stability
Peter J. Campbell
CELL (2012)
Signaling Network Crosstalk in Human Pluripotent Cells: A Smad2/3-Regulated Switch that Controls the Balance between Self-Renewal and Differentiation
Amar M. Singh et al.
CELL STEM CELL (2012)
Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
Ayse Ayhan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Low-grade serous carcinomas of the ovary contain very few point mutations
Sian Jones et al.
JOURNAL OF PATHOLOGY (2012)
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Elisabetta Kuhn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
Sohei Yamamoto et al.
MODERN PATHOLOGY (2012)
Reciprocal Regulation of Akt and Oct4 Promotes the Self-Renewal and Survival of Embryonal Carcinoma Cells
Yuanji Lin et al.
MOLECULAR CELL (2012)
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells
Hongxia Li et al.
CANCER BIOLOGY & THERAPY (2011)
EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis
Steffen Heeg et al.
CANCER SCIENCE (2011)
PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma
Sohei Yamamoto et al.
JOURNAL OF PATHOLOGY (2011)
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma
Elisabetta Kuhn et al.
MODERN PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
Daichi Maeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
Anne-Marie Bleau et al.
CELL STEM CELL (2009)
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
Anna Dubrovska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
How Telomeres Solve the End-Protection Problem
Titia de Lange
SCIENCE (2009)
Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells
Marcia Bellon et al.
BLOOD (2008)
Cellular senescence in vivo:: a barrier to tumorigenesis
Alexandre Prieur et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Lysophosphatidic Acid Activates Telomerase in Ovarian Cancer Cells Through Hypoxia-Inducible Factor-1 alpha and the PI3K Pathway
Kun Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Ovarian clear cell adenocarcinoma: a continuing enigma
David S. P. Tan et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis
P Vigano et al.
HUMAN REPRODUCTION UPDATE (2006)
ETS transcription factors and their emerging roles in human cancer
A Seth et al.
EUROPEAN JOURNAL OF CANCER (2005)
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes
C Pirker et al.
MELANOMA RESEARCH (2003)
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
V Hakin-Smith et al.
LANCET (2003)
Expression profiling in ovarian clear cell carcinoma identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma
A Tsuchiya et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Alternative lengthening of telomeres in mammalian cells
JD Henson et al.
ONCOGENE (2002)
The ETS-domain transcription factor family
AD Sharrocks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
